What radiologists should know about microRNA (miRNA) serum biomarkers for germ cell tumors
- PMID: 32804256
- DOI: 10.1007/s00261-020-02703-3
What radiologists should know about microRNA (miRNA) serum biomarkers for germ cell tumors
Abstract
MicroRNAs expressed by germ cell tumors represent a novel approach to detection of metastatic disease during staging, surveillance, and recurrence post-therapy. It has particular promise in settings of equivocal imaging, such as clinical stage I GCT, tumor marker negative stage IIA, or after chemotherapy. These miRNAs have the potential to change typical serum marker evaluation and imaging surveillance schedules.
Keywords: Germ cell tumor; NSGCT; Seminoma; Testicle; Tumor marker.
References
-
- Einhorn EH. Testicular cancer: an oncological success story. Clin Cancer Res December 1 1997 (3) (12) 2630-2632.
-
- Hilton S, Herr HW, Teitcher JB, Begg CB, Castéllino RA. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR Am J Roentgenol. 1997 Aug;169(2):521-5. DOI: 10.2214/ajr.169.2.9242768 - DOI - PubMed
-
- Bellin MF, Lebleu L, Meric JB. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom Imaging. 2003 Mar-Apr;28(2):155-63. https://doi.org/10.1007/s00261-001-0182-9
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
